A Bibliometric Analysis of Exosomes in Cardiovascular Diseases From 2001 to 2021

被引:78
作者
Ma, Dan [1 ]
Guan, Baoyi [1 ]
Song, Luxia [2 ]
Liu, Qiyu [2 ]
Fan, Yixuan [2 ]
Zhao, Lin [2 ]
Wang, Tongxin [2 ]
Zhang, Zihao [2 ]
Gao, Zhuye [1 ,3 ]
Li, Siming [1 ,3 ]
Xu, Hao [1 ,3 ]
机构
[1] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China
[2] Beijing Univ Chinese Med, Grad Sch, Beijing, Peoples R China
[3] China Acad Chinese Med Sci, Xiyuan Hosp, Natl Clin Res Ctr Chinese Med Cardiol, Beijing, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2021年 / 8卷
基金
中国国家自然科学基金;
关键词
cardiovascular disease; CiteSpace; VOSviewer; bibliometrics; cardiovascular diseases; MESENCHYMAL STEM-CELL; CIRCULATING EXTRACELLULAR VESICLES; CARDIOMYOCYTE APOPTOSIS; MYOCARDIAL-INFARCTION; DRUG-DELIVERY; CARDIAC-FUNCTION; BIOMARKERS; THERAPY; MIRNAS; CANCER;
D O I
10.3389/fcvm.2021.734514
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Exosomes in cardiovascular diseases (CVDs) have become an active research field with substantial value and potential. Nevertheless, there are few bibliometric studies in this field. We aimed to visualize the research hotspots and trends of exosomes in CVDs using a bibliometric analysis to help understand the future development of basic and clinical research. Methods: The articles and reviews regarding exosomes in the CVDs were culled from the Web of Science Core Collection, and knowledge maps were generated using CiteSpace and VOSviewer software. Results: A total of 1,039 articles were included. The number of exosome articles in the CVDs increased yearly. These publications came from 60 countries/regions, led by the US and China. The primary research institutions were Shanghai Jiao Tong University and Nanjing Medical University. Circulation Research was the journal and co-cited journal with the most studies. We identified 473 authors among which Lucio Barile had the most significant number of articles and Thery C was co-cited most often. After analysis, the most common keywords are myocardium infarction, microRNA and mesenchymal stem cells. Ischemic heart disease, pathogenesis, regeneration, stem cells, targeted therapy, biomarkers, cardiac protection, and others are current and developing areas of study. Conclusion: We identified the research hotspots and trends of exosomes in CVDs using bibliometric and visual methods. Research on exosomes is flourishing in the cardiovascular medicine. Regenerative medicine, exosome engineering, delivery vehicles, and biomarkers will likely become the focus of future research.
引用
收藏
页数:17
相关论文
共 103 条
  • [1] Exosomes in Myocardial Repair: Advances and Challenges in the Development of Next-Generation Therapeutics
    Adamiak, Marta
    Sahoo, Susmita
    [J]. MOLECULAR THERAPY, 2018, 26 (07) : 1635 - 1643
  • [2] Ageing and mesenchymal stem cells derived exosomes: Molecular insight and challenges
    Ahmadi, Mahdi
    Rezaie, Jafar
    [J]. CELL BIOCHEMISTRY AND FUNCTION, 2021, 39 (01) : 60 - 66
  • [3] Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia
    Akbari, Ali
    Rezaie, Jafar
    [J]. STEM CELL RESEARCH & THERAPY, 2020, 11 (01)
  • [4] Free and hydrogel encapsulated exosome-based therapies in regenerative medicine
    Akbari, Ali
    Jabbari, Nassrollah
    Sharifi, Roholah
    Ahmadi, Mahdi
    Vahhabi, Ali
    Seyedzadeh, Seyyed Javad
    Nawaz, Muhammad
    Szafert, Slawomir
    Mahmoodi, Monireh
    Jabbari, Esmaiel
    Asghari, Rahim
    Rezaie, Jafar
    [J]. LIFE SCIENCES, 2020, 249
  • [5] The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning
    Andreadou, Ioanna
    Iliodromitis, Efstathios K.
    Rassaf, Tienush
    Schulz, Rainer
    Papapetropoulos, Andreas
    Ferdinandy, Peter
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (06) : 1587 - 1606
  • [6] Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury
    Arslan, Fatih
    Lai, Ruenn Chai
    Smeets, Mirjam B.
    Akeroyd, Lars
    Choo, Andre
    Aguor, Eissa N. E.
    Timmers, Leo
    van Rijen, Harold V.
    Doevendans, Pieter A.
    Pasterkamp, Gerard
    Lim, Sai Kiang
    de Kleijn, Dominique P.
    [J]. STEM CELL RESEARCH, 2013, 10 (03) : 301 - 312
  • [7] Application of stem cell-derived exosomes in ischemic diseases: opportunity and limitations
    Babaei, Majid
    Rezaie, Jafar
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [8] Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A
    Barile, Lucio
    Cervio, Elisabetta
    Lionetti, Vincenzo
    Milano, Giuseppina
    Ciullo, Alessandra
    Biemmi, Vanessa
    Bolis, Sara
    Altomare, Claudia
    Matteucci, Marco
    Di Silvestre, Dario
    Brambilla, Francesca
    Fertig, Tudor Emanuel
    Torre, Tiziano
    Demertzis, Stefanos
    Mauri, Pierluigi
    Moccetti, Tiziano
    Vassalli, Giuseppe
    [J]. CARDIOVASCULAR RESEARCH, 2018, 114 (07) : 992 - 1005
  • [9] Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction
    Barile, Lucio
    Lionetti, Vincenzo
    Cervio, Elisabetta
    Matteucci, Marco
    Gherghiceanu, Mihaela
    Popescu, Laurentiu M.
    Torre, Tiziano
    Siclari, Francesco
    Moccetti, Tiziano
    Vassalli, Giuseppe
    [J]. CARDIOVASCULAR RESEARCH, 2014, 103 (04) : 530 - 541
  • [10] Development and regulation of exosome-based therapy products
    Batrakova, Elena V.
    Kim, Myung Soo
    [J]. WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2016, 8 (05) : 744 - 757